IRWD Ironwood Pharmaceuticals, Inc. - Class A Common Stock
$4,25
السعر · أغسطس 21, 2026
البيانات الأساسية اعتبارًا من أغسطس 6, 2026
نطاق 52 أسبوعًا
$1–$6
68% of range
تقييم المحللين
BUY
10 analysts
السعر المستهدف
$6
+44% upside
P/E (TTM)
28.3
ROE
-8.5%
هامش صافي الربح
8.1%
حول Ironwood Pharmaceuticals, Inc. - Class A Common Stock نظرة عامة على الشركة من ويكيبيديا
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
اقرأ المزيد
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Microbia was founded by postdocs from the lab of Gerald Fink at the Whitehead Institute to commercialize approaches that had been developed in the lab to improve industrial fermentation of fungi, to genetically engineer them to produce secondary metabolites more efficiently or to produce new ones as leads for drug discovery or as products for use in industry, and to identify drug targets in fungi for antifungal drug discovery. In 2002 the company hired John Talley to lead their antifungal drug discovery efforts, which at the time were focused on identifying small molecules that could inhibit fungal invasins, along with Mark Currie who had also worked at Searle division of Monsanto with Talley, and then had gone to Sepracor, and also Richard Bailey, who had run Monsanto's nutritional business. Currie directed the efforts that led to the discovery of linaclotide, which was based on an enterotoxin produced by some strains of Escherichia coli that cause traveler’s diarrhea.
By 2004 the company had raised $99M and was preparing a Phase I trial for linaclotide. By 2006 Microbia was starting to struggle with the different challenges and expenses of drug development, along with its industrial fermentation business and drug discovery efforts, and made the decision to split in two, with "Microbia Precision Engineering" focused on industrial applications led by Bailey and Microbia focused on drug discovery and development. Tate & Lyle invested $7M in the Microbia spinout and took a board seat in 2006. Microbia changed its name to Ironwood in 2008 and shortened the name of the industrial business to Microbia.
By 2009, Ironwood had raised a total of $281M. In early 2010 Ironwood held its IPO, which priced at $11.25 a share, below the target price of $14. Later that year it sold its interests in Microbia to DSM for an undisclosed sum.
Linaclotide (Linzess in the US and Mexico, and as Constella elsewhere), a drug used to treat irritable bowel syndrome with constipation and chronic constipation with no known cause, was approved in the US and Europe in 2012. Most of the marketing rights were licensed to Allergan and Astellas.
It was developing a drug called IW-9179 or recanaclotide but abandoned it in 2016.
Soclenicant (BNC-210; IW-2143) is an anxiolytic that Ironwood licensed and performed R&D on and then abandoned.
In April 2018, the shares of Ironwood Pharmaceuticals closed up more than 10 percent on the news of biotech activist investor, Alex Denner joining its board.
Despite having a billion dollar drug in Linzess, Ironwood - through a series of confounding decisions by management - has seen its stock price crater from a high of $21.16 on July 17, 2018, to its current price of 77 CENTS at the close of trading on August 1, 2025.
== References ==
المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗
IRWD لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
السعر
$4.25
القيمة السوقية
$693M
P/E (TTM)
28.3
ربح السهم (آخر 12 شهرًا)
$0.15
الإيرادات (آخر 12 شهرًا)
$296M
عائد التوزيعات
—
ROE
-8.5%
D/E الدين/حقوق الملكية
—
نطاق 52 أسبوعًا
$1 – $6
IRWD مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
Configure
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
الإيرادات وصافي الدخل
$296M
2016-12-31
→
2025-12-31
ربح السهم
$0.15
2018-12-31
→
2025-12-31
التدفق النقدي الحر
$127M
2016-12-31
→
2025-12-31
الهوامش
8.1%
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
المقياس
اتجاه 5 سنوات
IRWD
متوسط الأقران
P/E (TTM)
28.3
70.4
P/S (TTM) (السعر / المبيعات (آخر 12 شهرًا))
2.3
8.3
P/B (السعر / القيمة الدفترية)
-2.6
2.2
Price / FCF (السعر / التدفق النقدي الحر)
5.5
—
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
المقياس
اتجاه 5 سنوات
IRWD
متوسط الأقران
Operating Margin (هامش التشغيل)
33.3%
—
Net Profit Margin (هامش صافي الربح)
8.1%
-330.2%
ROA (العائد على الأصول)
6.4%
-35.6%
ROE
-8.5%
-37.4%
ROIC
-12.9%
—
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
المقياس
اتجاه 5 سنوات
IRWD
متوسط الأقران
Current Ratio (النسبة الحالية)
1.1
7.1
Quick Ratio (النسبة السريعة)
1.1
—
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
المقياس
اتجاه 5 سنوات
IRWD
متوسط الأقران
Revenue YoY (الإيرادات مقارنة بالعام السابق)
-15.7%
—
Revenue CAGR 3Y (معدل نمو الإيرادات السنوي المركب لـ 3 سنوات)
-10.3%
—
Revenue CAGR 5Y (معدل نمو الإيرادات السنوي المركب لـ 5 سنوات)
-5.3%
—
EPS YoY (ربحية السهم على أساس سنوي)
1400.0%
—
Net Income YoY (صافي الدخل مقارنة بالعام السابق)
2629.2%
—
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
المقياس
اتجاه 5 سنوات
IRWD
متوسط الأقران
IRWD توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
شراء
10 محللين
- شراء قوي 2 20,0%
- شراء 5 50,0%
- احتفاظ 3 30,0%
- بيع 0 0,0%
- بيع قوي 0 0,0%
السعر المستهدف لمدة 12 شهرًا
4 محللين · 2026-08-19
الوسيط
$5.35
المتوسط
$6.10
الآن
$4.25
منخفض
$3.70
مرتفع
$10.00
السعر المستهدف الوسيط
$5.35
+25,9%
السعر المستهدف المتوسط
$6.10
+43,5%
سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
متوسط المفاجأة
0.01%
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 30 يونيو، 2026 | $0.31 | $0.36 | -0.05% |
| 31 مارس، 2026 | $0.24 | $0.24 | -0.00% |
| 31 ديسمبر، 2025 | $-0.01 | $0.01 | -0.02% |
| 30 سبتمبر، 2025 | $0.24 | $0.10 | 0.14% |
| 30 يونيو، 2025 | $0.14 | $0.04 | 0.10% |
| 31 مارس، 2025 | $-0.14 | $-0.05 | -0.09% |
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | — |
| TECX | $391M | -5.2 | — | — | -27.7% | — |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | — |
| SGMT | — | -3.7 | — | — | -42.3% | — |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | — |
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 16
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $296M | $351M | $443M | $411M | $414M | $390M | $428M | $347M | $298M | $274M | $150M | $76M | |
| Cost of Revenue | · | · | · | · | · | $3M | $24M | $33M | $19M | $2M | $12.0K | $5M | |
| R&D Expense | $95M | $111M | $116M | $44M | $70M | $88M | $115M | $101M | $88M | $139M | $109M | $102M | |
| SG&A Expense | $82M | $144M | $158M | $116M | $111M | $140M | $172M | $220M | $231M | $173M | $125M | $118M | |
| Operating Expenses | $198M | $258M | $1.39B | $160M | $181M | $247M | $308M | $497M | $314M | $326M | $252M | $246M | |
| Operating Income | $99M | $93M | $-945M | $250M | $232M | $143M | $120M | $-151M | $-15M | $-52M | $-102M | $-169M | |
| Interest Expense | · | · | $22M | $8M | $31M | $29M | $37M | $38M | $36M | $39M | $31M | $21M | |
| Other Non-op | $193.0K | $640.0K | $-3M | $2M | $-32M | $-34M | $-61M | $-43M | $-40M | $-30M | $-41M | $-20M | |
| Pretax Income | $70M | $65M | $-948M | $252M | $201M | $109M | $59M | $-194M | · | · | · | · | |
| Income Tax | $46M | $64M | $83M | $77M | $-328M | $3M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $24M | $880.0K | $-1.00B | $175M | $528M | $106M | $22M | $-282M | $-117M | $-82M | $-143M | · | |
| EPS (Basic) | $0.15 | $0.01 | $-6.45 | $1.13 | $3.26 | $0.67 | $0.14 | $-1.85 | · | · | · | · | |
| EPS (Diluted) | $0.15 | $0.01 | $-6.45 | $0.96 | $3.21 | $0.66 | $0.14 | $-1.85 | · | · | · | · | |
| Shares (Basic) | 161,842,000 | 159,083,000 | 155,435,000 | 154,366,000 | 162,245,000 | 159,427,000 | 156,023,000 | 152,634,000 | · | · | · | · | |
| Shares (Diluted) | 162,983,000 | 160,084,000 | 155,435,000 | 186,312,000 | 164,418,000 | 160,655,000 | 156,023,000 | 152,634,000 | · | · | · | · | |
| EBITDA | $100M | $94M | $-944M | $252M | $234M | $145M | $126M | $-233M | · | $-42M | $-90M | $-157M |
الميزانية العمومية 28
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $215M | $89M | $92M | $656M | $620M | $363M | $177M | $173M | $126M | $54M | $261M | $74M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $96M | $251M | $178M | $174M | |
| Receivables | $47M | $82M | $129M | $115M | $114M | $122M | $11M | $21M | $3M | $933.0K | $3M | $10.0K | |
| Inventory | · | · | · | · | · | · | $648.0K | · | $735.0K | $1M | · | $5M | |
| Prepaid Expense | $12M | $12M | $12M | $8M | $9M | $9M | $11M | $10M | $7M | $9M | $6M | $9M | |
| Current Assets | $274M | $182M | $233M | $781M | $745M | $496M | $307M | $266M | $312M | $380M | $500M | $288M | |
| PP&E (Net) | $3M | $4M | $6M | $6M | $8M | $9M | $12M | $8M | $17M | $21M | $21M | $30M | |
| PP&E (Gross) | $11M | $13M | $14M | $17M | $17M | $21M | $23M | $33M | $86M | $83M | $78M | $83M | |
| Accum. Depreciation | $8M | $8M | $9M | $11M | $10M | $12M | $10M | $26M | $69M | $62M | $57M | $53M | |
| Goodwill | · | · | · | · | · | · | $785.0K | $785.0K | $785.0K | $785.0K | · | · | |
| Intangibles | $2M | $3M | $4M | · | · | · | · | · | $160M | $166M | · | · | |
| Other Non-current Assets | $5M | $6M | $4M | $847.0K | $1M | $943.0K | $790.0K | $89.0K | $870.0K | $1M | $3M | $3M | |
| Total Assets | $397M | $351M | $471M | $1.10B | $1.13B | $559M | $403M | $332M | $606M | $710M | $619M | $329M | |
| Accounts Payable | $3M | $2M | $8M | $483.0K | $935.0K | $661.0K | $4M | $15M | $16M | $18M | $9M | $10M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | $38M | $23M | $23M | |
| Short-term Debt | · | · | · | · | · | · | · | $48M | · | · | $25M | $11M | |
| Current Liabilities | $242M | $39M | $276M | $26M | $162M | $32M | $41M | $120M | $66M | $91M | $76M | $61M | |
| Capital Leases | $10M | $12M | $15M | $17M | $18M | $20M | $22M | $158.0K | · | $82.0K | $306.0K | $3M | |
| Other Non-current Liabilities | $22M | $17M | $28M | $10M | $4M | $2M | $734.0K | $3M | $5M | $8M | $10M | · | |
| Total Liabilities | $659M | · | · | · | · | · | · | · | · | · | · | · | |
| Long-term Debt | · | $199M | $398M | $396M | $454M | $430M | · | · | · | · | $221M | · | |
| Total Debt | · | · | · | · | · | · | · | $48M | · | · | $25M | $11M | |
| Common Stock | $163.0K | $160.0K | $156.0K | $154.0K | $162.0K | $161.0K | $158.0K | $154.0K | · | · | · | · | |
| Retained Earnings | $-1.67B | $-1.70B | $-1.70B | $-696M | $-938M | $-1.47B | $-1.57B | $-1.59B | $-1.31B | $-1.19B | $-1.11B | $-967M | |
| AOCI | $-1M | $923.0K | $-3M | · | · | · | · | · | $-79.0K | $-7.0K | $-86.0K | $-19.0K | |
| Stockholders' Equity | $-262M | $-301M | $-346M | $652M | $606M | $63M | $-93M | $-196M | $10M | $67M | $95M | $89M | |
| Liabilities + Equity | $397M | $351M | $471M | $1.10B | $1.13B | $559M | $403M | $332M | $606M | $710M | $619M | $329M | |
| Shares Outstanding | 163,058,316 | 160,205,899 | 156,354,238 | 154,026,949 | 162,036,461 | 160,616,675 | 157,535,962 | 154,414,691 | · | · | · | · |
التدفق النقدي 18
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $1M | $2M | $2M | $6M | $4M | $6M | $10M | $12M | $12M | |
| Stock-based Comp | $17M | $30M | $32M | $27M | $22M | $31M | $31M | $41M | $31M | $29M | $25M | $26M | |
| Deferred Tax | $41M | $68M | $73M | $66M | $-333M | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | · | · | · | · | · | $8M | $6M | $981.0K | · | · | |
| Restructuring | $21M | $3M | $17M | · | $1M | $15M | $4M | $15M | · | · | · | $551.0K | |
| Other Non-cash | $44M | $4M | $1.08B | $5M | $43M | $29M | $-48M | $161M | · | · | · | · | |
| Operating Cash Flow | $127M | $104M | $183M | $274M | $262M | $169M | $11M | $-71M | $-101M | $-26M | $-107M | $-156M | |
| CapEx | $34.0K | $142.0K | $273.0K | $136.0K | $265.0K | $2M | $7M | $351.0K | $3M | $4M | $4M | $4M | |
| Investing Cash Flow | $-34.0K | $-142.0K | $-1.03B | $-136.0K | $-265.0K | $-2M | $-11M | $89M | $151M | $-178M | $-9M | $-57M | |
| Debt Issued | · | · | · | · | · | · | · | · | $146M | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $190M | |
| Stock Repurchased | · | · | · | $126M | $24M | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | $-126M | $-24M | · | · | · | · | · | · | $190M | |
| Financing Cash Flow | $216.0K | $-107M | $277M | $-238M | $-5M | $19M | $-1M | $30M | $20M | $-4M | $303M | $211M | |
| Net Change in Cash | $127M | $-4M | $-566M | $36M | $257M | $186M | $-2M | $48M | $71M | $-208M | $187M | · | |
| Taxes Paid | $4M | $8M | $10M | $5M | $3M | $2M | · | · | · | · | · | · | |
| Free Cash Flow | $127M | $103M | $183M | $274M | $262M | $167M | $4M | $-80M | · | $-30M | $-111M | $-159M | |
| Levered FCF | · | · | $160M | $268M | $180M | $138M | · | · | · | · | · | · |
الربحية 7
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 33.3% | 26.5% | -213.5% | 61.0% | 56.1% | 36.7% | 28.0% | -68.9% | · | -18.9% | -68.3% | -221.6% | |
| Net Margin | 8.1% | 0.25% | -226.4% | 42.6% | 127.7% | 27.3% | 5.0% | -81.5% | · | · | · | · | |
| Pretax Margin | 23.6% | 18.6% | -214.1% | 61.5% | 48.5% | 28.0% | · | · | · | · | · | · | |
| EBITDA Margin | 33.6% | 26.8% | -213.3% | 61.3% | 56.5% | 37.3% | 29.3% | -67.2% | · | -15.2% | -60.5% | -205.4% | |
| ROA | 6.4% | 0.21% | -127.5% | 15.7% | 62.7% | 22.1% | 5.9% | -60.2% | · | · | · | · | |
| ROE | -8.5% | -0.27% | -654.9% | 29.9% | 94.6% | 309.8% | -17.5% | 143.5% | · | · | · | · | |
| ROIC | -12.9% | -0.42% | 297.1% | 26.6% | 101.0% | 222.6% | · | · | · | · | · | · |
السيولة والملاءة 4
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 4.7 | 0.8 | 30.6 | 4.6 | 15.4 | 7.5 | 2.2 | · | 4.2 | 6.5 | 4.8 | |
| Quick Ratio | 1.1 | 4.4 | 0.8 | 30.2 | 4.5 | 15.1 | 4.6 | 1.6 | · | 3.4 | 5.8 | 4.1 | |
| Debt / Equity | · | · | · | · | · | · | · | -0.2 | · | · | 0.3 | 0.1 | |
| Interest Coverage | · | · | -43.7 | 32.9 | 7.5 | 4.8 | 3.3 | -6.3 | · | -1.3 | -3.3 | -8.0 |
الكفاءة 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.9 | 0.6 | 0.4 | 0.5 | 0.8 | 1.2 | 0.7 | · | 0.4 | 0.3 | 0.2 | |
| Inventory Turnover | · | · | · | · | · | · | 34.5 | · | · | 3.5 | · | 1.9 | |
| Receivables Turnover | 4.6 | 3.3 | 3.6 | 3.6 | 3.5 | 5.8 | 26.6 | 28.7 | · | 143.5 | 103.4 | 292.3 |
معدلات النمو 9
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -15.7% | -20.6% | 7.8% | -0.76% | 6.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -10.3% | -5.3% | 4.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -5.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 1400.0% | · | · | -70.1% | 386.4% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -46.1% | -85.4% | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -25.7% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 2629.2% | · | · | -66.9% | 397.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -48.4% | -88.1% | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -25.7% | · | · | · | · | · | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 10
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $296M | $351M | $443M | $411M | $414M | $390M | $428M | $347M | $298M | $274M | $150M | $76M | |
| Net Income TTM | $24M | $880.0K | $-1.00B | $175M | $528M | $106M | $22M | $-282M | $-117M | $-82M | $-143M | · | |
| Market Cap | $550M | $710M | $1.79B | $1.91B | $1.89B | $1.83B | $2.10B | · | · | · | · | · | |
| P/E | 22.5 | 443.0 | -1.8 | 12.9 | 3.6 | 17.3 | 95.1 | -4.7 | -5.3 | -5.4 | -4.1 | -5.4 | |
| P/S | 1.9 | 2.0 | 4.0 | 4.6 | 4.6 | 4.7 | 4.9 | · | · | · | · | · | |
| P/B | -2.1 | -2.4 | -5.2 | 2.9 | 3.1 | 29.2 | -22.5 | · | · | · | · | · | |
| P / Tangible Book | · | · | · | 2.9 | 3.1 | 29.2 | · | · | · | · | · | · | |
| P / Cash Flow | 4.3 | 6.9 | 9.8 | 7.0 | 7.2 | 10.8 | 195.5 | · | · | · | · | · | |
| P / FCF | 4.3 | 6.9 | 9.8 | 7.0 | 7.2 | 11.0 | 593.0 | · | · | · | · | · | |
| Earnings Yield | 4.5% | 0.23% | -56.4% | 7.8% | 27.5% | 5.8% | 1.1% | -21.3% | -19.0% | -18.6% | -24.5% | -18.6% |
قائمة الدخل 15
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $113M | $107M | $48M | $122M | $85M | $41M | $91M | $92M | $94M | $75M | $118M | $114M | $107M | $104M | $107M | $109M | |
| R&D Expense | $22M | $22M | $22M | $22M | $23M | $27M | $25M | $30M | $30M | $26M | $36M | $33M | $35M | $13M | $10M | $12M | |
| SG&A Expense | $11M | $12M | $19M | $22M | $17M | $24M | $34M | $36M | $37M | $38M | $39M | $36M | $52M | $31M | $28M | $29M | |
| Operating Expenses | $34M | $34M | $41M | $47M | $40M | $70M | $59M | $66M | $69M | $64M | $80M | $74M | $1.19B | $44M | $39M | $40M | |
| Operating Income | $79M | $73M | $7M | $75M | $45M | $-29M | $31M | $26M | $25M | $11M | $38M | $40M | $-1.08B | $60M | $68M | $68M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $7M | · | $10M | $2M | $2M | · | $2M | |
| Other Non-op | $42.0K | $42.0K | $77.0K | $40.0K | $39.0K | $37.0K | $21M | $-8M | $-6M | $-6M | $-7M | $-8M | $7M | $6M | $4M | $1M | |
| Pretax Income | $74M | $65M | $455.0K | $68M | $38M | $-36M | $24M | $17M | $19M | $5M | $30M | $32M | $-1.08B | $66M | $72M | $70M | |
| Income Tax | $22M | $24M | $3M | $28M | $14M | $1M | $22M | $14M | $20M | $9M | $32M | $18M | $13M | $20M | $23M | $20M | |
| Net Income | $51M | $41M | $-2M | $40M | $24M | $-37M | $2M | $4M | $-860.0K | $-4M | $-1M | $15M | $-1.06B | $46M | $49M | $50M | |
| EPS (Basic) | $0.31 | $0.25 | $-0.01 | $0.25 | $0.15 | $-0.23 | $0.01 | $0.02 | $-0.01 | $-0.03 | $-0.01 | $0.10 | $-6.84 | $0.30 | $0.31 | $0.33 | |
| EPS (Diluted) | $0.31 | $0.24 | $-0.01 | $0.23 | $0.14 | $-0.23 | $0.01 | $0.02 | $-0.01 | $-0.03 | $-0.01 | $0.09 | $-6.84 | $0.25 | $0.26 | $0.28 | |
| Shares (Basic) | 164,405,000 | 163,451,000 | -323,070,000 | 162,215,000 | 161,723,000 | 160,974,000 | -317,337,000 | 159,706,000 | 159,014,000 | 157,700,000 | -310,270,000 | 155,886,000 | 155,367,000 | 154,452,000 | -309,825,000 | 153,066,000 | |
| Shares (Diluted) | 167,179,000 | 166,690,000 | -352,592,000 | 177,764,000 | 176,837,000 | 160,974,000 | -316,862,000 | 160,232,000 | 159,014,000 | 157,700,000 | -373,503,000 | 186,891,000 | 155,367,000 | 186,680,000 | -372,569,000 | 184,465,000 | |
| EBITDA | $79M | $73M | · | $75M | $45M | $-29M | · | $26M | $25M | $11M | · | $40M | $-1.08B | $60M | · | $68M |
الميزانية العمومية 22
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $79M | $220M | $215M | $140M | $93M | $108M | $89M | $88M | $106M | $122M | $92M | $110M | $175M | $740M | $656M | $574M | |
| Receivables | $113M | $106M | $47M | $120M | $86M | $40M | $82M | $76M | $58M | $72M | $129M | $125M | $119M | $116M | · | $117M | |
| Prepaid Expense | $7M | $6M | $12M | $13M | $13M | $12M | $12M | $14M | $15M | $15M | $12M | $18M | $22M | $9M | · | $7M | |
| Current Assets | $199M | $332M | $274M | $274M | $192M | $161M | $182M | $179M | $178M | $208M | $233M | $254M | $318M | $866M | · | $699M | |
| PP&E (Net) | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $6M | $6M | $6M | $6M | · | $7M | |
| PP&E (Gross) | · | · | $11M | · | · | · | $13M | · | · | · | $14M | · | · | · | · | · | |
| Accum. Depreciation | · | · | $8M | · | · | · | $8M | · | · | · | $9M | · | · | · | · | · | |
| Intangibles | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | · | · | · | |
| Other Non-current Assets | $4M | $4M | $5M | $5M | $5M | $6M | $6M | $6M | $4M | $3M | $4M | $4M | $4M | $820.0K | · | $863.0K | |
| Total Assets | $285M | $435M | $397M | $396M | $343M | $327M | $351M | $390M | $396M | $439M | $471M | $524M | $603M | $1.16B | · | $1.04B | |
| Accounts Payable | $911.0K | $3M | $3M | $2M | $1M | $6M | $2M | $3M | $3M | $6M | $8M | $5M | $4M | $118.0K | · | $795.0K | |
| Current Liabilities | $33M | $236M | $242M | $243M | $233M | $48M | $39M | $49M | $46M | $252M | $276M | $281M | $305M | $24M | · | $27M | |
| Capital Leases | $9M | $9M | $10M | $10M | $11M | $12M | $12M | $13M | $13M | $14M | $15M | $15M | $16M | $16M | · | $17M | |
| Other Non-current Liabilities | $21M | $21M | $22M | $22M | $22M | $17M | $17M | $40M | $35M | $29M | $28M | $31M | $31M | $12M | · | $9M | |
| Total Liabilities | $447M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Long-term Debt | · | · | · | $200M | $199M | $199M | · | $199M | $199M | $398M | · | $397M | $397M | $397M | · | $396M | |
| Common Stock | $165.0K | $165.0K | $163.0K | $163.0K | $162.0K | $162.0K | $160.0K | $160.0K | $160.0K | $159.0K | $156.0K | $156.0K | $156.0K | $155.0K | · | $153.0K | |
| Retained Earnings | $-1.58B | $-1.63B | $-1.67B | $-1.67B | $-1.71B | $-1.74B | $-1.70B | $-1.70B | $-1.70B | $-1.70B | $-1.70B | $-1.70B | $-1.71B | $-651M | · | $-745M | |
| AOCI | $-324.0K | $-795.0K | $-1M | $-2M | $-2M | $294.0K | $923.0K | $-2M | $-470.0K | $-922.0K | $-3M | $-752.0K | · | · | · | · | |
| Stockholders' Equity | $-162M | $-217M | $-262M | $-264M | $-308M | $-334M | $-301M | $-311M | $-322M | $-331M | $-346M | $-323M | $-346M | $707M | · | $591M | |
| Liabilities + Equity | $285M | $435M | $397M | $396M | $343M | $327M | $351M | $390M | $396M | $439M | $471M | $524M | $603M | $1.16B | · | $1.04B | |
| Shares Outstanding | 165,239,947 | 164,613,406 | 163,058,316 | 162,678,647 | 162,434,130 | 161,809,432 | 160,205,899 | 160,015,888 | 159,739,001 | 158,957,123 | 156,354,238 | 156,125,676 | 156,027,648 | 155,346,103 | · | 153,319,417 |
التدفق النقدي 11
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $8M | $9M | $8M | $9M | $8M | $8M | $7M | $7M | $7M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $20M | $16M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $639.0K | $5M | · | · | · | · | |
| Operating Cash Flow | $58M | $5M | $75M | $48M | $-15M | $20M | $15M | $10M | $33M | $45M | $36M | $32M | $35M | $80M | $79M | $69M | |
| CapEx | · | · | $-1.0K | $2.0K | $2.0K | $31.0K | $0 | $16.0K | $58.0K | $68.0K | $211.0K | $49.0K | $0 | $13.0K | $-27.0K | $66.0K | |
| Investing Cash Flow | · | · | $1.0K | $-2.0K | $-2.0K | $-31.0K | $0 | $-16.0K | $-58.0K | $-68.0K | $-4M | $-23M | $-999M | $-13.0K | $27.0K | $-66.0K | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Financing Cash Flow | · | · | $122.0K | $0 | $88.0K | $6.0K | $-15M | $-27M | $-49M | $-16M | $-51M | $-75M | $399M | $4M | $3M | $797.0K | |
| Net Change in Cash | $-141M | $5M | $75M | $48M | $-16M | $20M | $348.0K | $-17M | $-16M | $29M | $-19M | $-65M | $-565M | $84M | $82M | $70M | |
| Free Cash Flow | · | · | · | · | · | $20M | · | · | · | $45M | · | · | · | $80M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $51M | · | · | · | $79M | · | · |
الربحية 7
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 70.2% | 68.1% | · | 61.8% | 53.2% | -70.8% | · | 28.0% | 26.5% | 14.7% | · | 35.2% | -1008.7% | 57.8% | · | 63.0% | |
| Net Margin | 45.4% | 38.3% | · | 32.8% | 27.7% | -90.9% | · | 4.0% | -0.91% | -5.6% | · | 13.5% | -989.2% | 43.9% | · | 46.3% | |
| Pretax Margin | 65.2% | 61.2% | · | 55.7% | 44.4% | -88.2% | · | 19.0% | 20.0% | 6.6% | · | 28.1% | -1002.2% | 63.3% | · | 64.3% | |
| EBITDA Margin | 70.2% | 68.1% | · | 61.8% | 53.2% | -70.8% | · | 28.0% | 26.5% | 14.7% | · | 35.2% | -1008.7% | 57.8% | · | 63.0% | |
| ROA | 16.3% | 10.7% | · | 10.2% | 6.4% | -9.8% | · | 0.80% | -0.17% | -0.52% | · | 2.0% | -131.9% | 4.3% | · | 4.8% | |
| ROE | -21.8% | -14.8% | · | -13.9% | -7.5% | 11.2% | · | -1.1% | 0.26% | -2.2% | · | 11.4% | -1279.3% | 7.4% | · | 8.6% | |
| ROIC | -34.1% | -20.9% | · | -16.8% | -9.2% | 9.0% | · | -1.7% | 0.35% | 2.8% | · | -5.4% | 317.2% | 5.9% | · | 8.3% |
السيولة والملاءة 3
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | 1.4 | · | 1.1 | 0.8 | 3.3 | · | 3.6 | 3.9 | 0.8 | · | 0.9 | 1.0 | 36.3 | · | 25.8 | |
| Quick Ratio | 5.8 | 1.4 | · | 1.1 | 0.8 | 3.1 | · | 3.3 | 3.6 | 0.8 | · | 0.8 | 1.0 | 35.9 | · | 25.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 1.5 | · | 4.1 | -588.7 | 39.4 | · | 44.9 |
الكفاءة 2
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.3 | · | 0.3 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.1 | 1.5 | · | 1.2 | 1.2 | 0.7 | · | 0.9 | 1.1 | 0.8 | · | 0.9 | 1.0 | 1.0 | · | 1.0 |
التقييم (آخر 12 شهرًا) 10
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $389M | $362M | · | $339M | $309M | $318M | · | $378M | $401M | $414M | · | $432M | $427M | $417M | · | $421M | |
| Net Income TTM | $130M | $102M | · | $29M | $-8M | $-32M | · | $-2M | $9M | $-1.05B | · | $-952M | $-917M | $182M | · | $168M | |
| Market Cap | $696M | $578M | · | $213M | $117M | $238M | · | $659M | $1.04B | $1.38B | · | $1.50B | $1.66B | $1.63B | · | $1.59B | |
| P/E | 5.5 | 5.8 | · | 8.7 | -12.0 | -7.0 | · | -137.3 | 163.0 | -1.3 | · | -1.5 | -1.8 | 10.4 | · | 10.9 | |
| P/S | 1.8 | 1.6 | · | 0.6 | 0.4 | 0.7 | · | 1.7 | 2.6 | 3.3 | · | 3.5 | 3.9 | 3.9 | · | 3.8 | |
| P/B | -4.3 | -2.7 | · | -0.8 | -0.4 | -0.7 | · | -2.1 | -3.2 | -4.2 | · | -4.7 | -4.8 | 2.3 | · | 2.7 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | 2.3 | · | 2.7 | |
| P / Cash Flow | · | 112.8 | · | · | · | 11.9 | · | · | · | 30.8 | · | · | · | 20.4 | · | · | |
| P / FCF | · | · | · | · | · | 11.9 | · | · | · | 30.8 | · | · | · | 20.4 | · | · | |
| Earnings Yield | 18.3% | 17.1% | · | 11.5% | -8.3% | -14.3% | · | -0.73% | 0.61% | -78.0% | · | -64.7% | -56.8% | 9.6% | · | 9.2% |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الإيرادات | $296M | $351M | $443M | $411M | $414M |
| هامش الربح التشغيلي % | 33.3% | 26.5% | -213.5% | 61.0% | 56.1% |
| صافي الدخل | $24M | $880.0K | $-1.00B | $175M | $528M |
| EPS المخفف | $0.15 | $0.01 | $-6.45 | $0.96 | $3.21 |
الميزانية العمومية
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| النسبة الحالية | 1.1 | 4.7 | 0.8 | 30.6 | 4.6 |
| النسبة السريعة | 1.1 | 4.4 | 0.8 | 30.2 | 4.5 |
التدفق النقدي
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $127M | $103M | $183M | $274M | $262M |
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
📊
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.
الملاك المؤسسيون (13F) 230 مقدمي إقرار · $468.6M إجمالي · حتى تاريخ 30 يونيو، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
النشاط المؤسسي — Q2 2026 مقابل الربع السابق
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 25 (-34 مقابل الربع السابق) | 32 (+7 مقابل الربع السابق) | 76 (-3 مقابل الربع السابق) | 80 (+21 مقابل الربع السابق) | -16.6M |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | $58653720 | 13932000 | 12,52% | الأسهم |
| Sarissa Capital Management LP | $38684153 | 9188635 | 8,26% | الأسهم |
| STATE STREET CORP | $37088420 | 8809601 | 7,92% | الأسهم |
| RENAISSANCE TECHNOLOGIES LLC | $33651481 | 7993226 | 7,18% | الأسهم |
| VANGUARD CAPITAL MANAGEMENT LLC | $27821819 | 6608508 | 5,94% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $25463128 | 6048249 | 5,43% | الأسهم |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $23211225 | 5513355 | 4,95% | الأسهم |
| TWO SIGMA INVESTMENTS, LP | $19181135 | 4556089 | 4,09% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $18001965 | 4275108 | 3,84% | الأسهم |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $17117708 | 4065964 | 3,65% | الأسهم |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $13902439 | 3302242 | 2,97% | الأسهم |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $12701945 | 3017089 | 2,71% | الأسهم |
| TWO SIGMA ADVISERS, LP | $10582137 | 3140100 | 2,26% | الأسهم |
| DIMENSIONAL FUND ADVISORS LP | $10183788 | 2418952 | 2,17% | الأسهم |
| MACKENZIE FINANCIAL CORP | $9967146 | 2367493 | 2,13% | الأسهم |
| GOLDMAN SACHS GROUP INC | $8089418 | 1921477 | 1,73% | الأسهم |
| Connor, Clark & Lunn Investment Management Ltd. | $7622630 | 1810601 | 1,63% | الأسهم |
| Hillsdale Investment Management Inc. | $5264302 | 1250428 | 1,12% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $4379810 | 1040335 | 0,93% | الأسهم |
| MARSHALL WACE, LLP | $4248425 | 1009127 | 0,91% | الأسهم |
| FMR LLC | $3818234 | 906944 | 0,81% | الأسهم |
| STATE OF WISCONSIN INVESTMENT BOARD | $3277548 | 778515 | 0,70% | الأسهم |
| BlackRock, Inc. | $3034593 | 720806 | 0,65% | الأسهم |
| MORGAN STANLEY | $2899132 | 688630 | 0,62% | الأسهم |
| VICTORY CAPITAL MANAGEMENT INC | $2772104 | 658457 | 0,59% | الأسهم |
| IEQ CAPITAL, LLC | $2364286 | 561588 | 0,50% | الأسهم |
| Vanguard Global Advisers, LLC | $2361970 | 561038 | 0,50% | الأسهم |
| CITADEL ADVISORS LLC | $2115117 | 502403 | 0,45% | الأسهم |
| PRUDENTIAL FINANCIAL INC | $2060370 | 489399 | 0,44% | الأسهم |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $1897127 | 540492 | 0,40% | الأسهم |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $1847815 | 438911 | 0,39% | الأسهم |
| Inspire Investing, LLC | $1789893 | 509941 | 0,38% | الأسهم |
| SEGALL BRYANT & HAMILL, LLC | $1717949 | 408064 | 0,37% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1670528 | 396800 | 0,36% | عقد خيار البيع |
| Man Group plc | $1650813 | 392117 | 0,35% | الأسهم |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1641029 | 389793 | 0,35% | الأسهم |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $1579962 | 375288 | 0,34% | الأسهم |
| RITHOLTZ WEALTH MANAGEMENT | $1515996 | 360094 | 0,32% | الأسهم |
| CM Management, LLC | $1473500 | 350000 | 0,31% | الأسهم |
| Qube Research & Technologies Ltd | $1465017 | 347985 | 0,31% | الأسهم |
| Robeco Institutional Asset Management B.V. | $1444022 | 342998 | 0,31% | الأسهم |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $1441054 | 342293 | 0,31% | الأسهم |
| Virtus Investment Advisers, LLC | $1341298 | 318598 | 0,29% | الأسهم |
| CWA Asset Management Group, LLC | $1222441 | 290366 | 0,26% | الأسهم |
| GLOBEFLEX CAPITAL L P | $1093796 | 259809 | 0,23% | الأسهم |
| VANGUARD GROUP INC | $1025525 | 304310 | 0,22% | الأسهم |
| CWM, LLC | $976542 | 278217 | 0,21% | الأسهم |
| Bank of New York Mellon Corp | $950858 | 225857 | 0,20% | الأسهم |
| CITIGROUP INC | $915128 | 217370 | 0,20% | الأسهم |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $913316 | 219445 | 0,19% | الأسهم |
| RHUMBLINE ADVISERS | $863439 | 205095 | 0,18% | الأسهم |
| MARTINGALE ASSET MANAGEMENT L P | $863013 | 204991 | 0,18% | الأسهم |
| EVOLVE PRIVATE WEALTH, LLC | $786697 | 186864 | 0,17% | الأسهم |
| Vident Advisory, LLC | $761711 | 180929 | 0,16% | الأسهم |
| Cerity Partners LLC | $734490 | 174463 | 0,16% | الأسهم |
| KLP KAPITALFORVALTNING AS | $733382 | 174200 | 0,16% | الأسهم |
| Mariner, LLC | $709288 | 168472 | 0,15% | الأسهم |
| OMERS ADMINISTRATION Corp | $669432 | 159010 | 0,14% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $666443 | 158300 | 0,14% | عقد خيار الشراء |
| Rafferty Asset Management, LLC | $643616 | 152878 | 0,14% | الأسهم |
| WELLINGTON MANAGEMENT GROUP LLP | $640299 | 152090 | 0,14% | الأسهم |
| Quantinno Capital Management LP | $634043 | 150604 | 0,14% | الأسهم |
| WELLS FARGO & COMPANY/MN | $626179 | 148736 | 0,13% | الأسهم |
| JPMORGAN CHASE & CO | $622047 | 144662 | 0,13% | الأسهم |
| ALLIANCEBERNSTEIN L.P. | $581923 | 165790 | 0,12% | الأسهم |
| FIFTH THIRD BANCORP | $558869 | 132748 | 0,12% | الأسهم |
| CANADA PENSION PLAN INVESTMENT BOARD | $551089 | 130900 | 0,12% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $544088 | 129237 | 0,12% | الأسهم |
| HSBC HOLDINGS PLC | $541600 | 126100 | 0,12% | الأسهم |
| Arax Advisory Partners | $534526 | 126966 | 0,11% | الأسهم |
| MERCER GLOBAL ADVISORS INC /ADV | $531134 | 126160 | 0,11% | الأسهم |
| JANE STREET GROUP, LLC | $526040 | 124950 | 0,11% | الأسهم |
| D. E. Shaw & Co., Inc. | $517438 | 122907 | 0,11% | الأسهم |
| Optimist Retirement Group LLC | $429647 | 102054 | 0,09% | الأسهم |
| State of Wyoming | $428498 | 101781 | 0,09% | الأسهم |
| Cercano Management LLC | $426801 | 101378 | 0,09% | الأسهم |
| AMERIPRISE FINANCIAL INC | $419004 | 99526 | 0,09% | الأسهم |
| CITADEL ADVISORS LLC | $413843 | 98300 | 0,09% | عقد خيار البيع |
| Engineers Gate Manager LP | $412799 | 98052 | 0,09% | الأسهم |
| MetLife Investment Management, LLC | $405036 | 96208 | 0,09% | الأسهم |
| Integrated Quantitative Investments LLC | $394431 | 93689 | 0,08% | الأسهم |
| FULLER & THALER ASSET MANAGEMENT, INC. | $380251 | 90321 | 0,08% | الأسهم |
| BARCLAYS PLC | $369584 | 87787 | 0,08% | الأسهم |
| WINTON GROUP Ltd | $354297 | 84156 | 0,08% | الأسهم |
| PROFUND ADVISORS LLC | $327344 | 77754 | 0,07% | الأسهم |
| CITADEL ADVISORS LLC | $319960 | 76000 | 0,07% | عقد خيار الشراء |
| SmartHarvest Portfolios, LLC | $317695 | 75462 | 0,07% | الأسهم |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $317569 | 75432 | 0,07% | الأسهم |
| Pallas Capital Advisors LLC | $311523 | 73996 | 0,07% | الأسهم |
| CAPTRUST FINANCIAL ADVISORS | $301883 | 71706 | 0,06% | الأسهم |
| Squarepoint Ops LLC | $281645 | 66899 | 0,06% | الأسهم |
| Invesco Ltd. | $275835 | 65519 | 0,06% | الأسهم |
| Vanguard Personalized Indexing Management, LLC | $270227 | 64187 | 0,06% | الأسهم |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $252284 | 59925 | 0,05% | الأسهم |
| AXQ CAPITAL, LP | $197988 | 47028 | 0,04% | الأسهم |
| Focus Partners Wealth | $189113 | 44920 | 0,04% | الأسهم |
| Police & Firemen's Retirement System of New Jersey | $185724 | 44115 | 0,04% | الأسهم |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $180693 | 42920 | 0,04% | الأسهم |
| NEW YORK STATE COMMON RETIREMENT FUND | $176268 | 41869 | 0,04% | الأسهم |
| BRIGHTON JONES LLC | $167900 | 39881 | 0,04% | الأسهم |
المطلعون على الشركة 40 من المطلعين · مسؤولون 18 · مديرون 22
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| Thomas A Mccourt | Chief Executive Officer | 10 مارس، 2026 A | 1898838 | 0 | 2 | $-739929 |
| Mark Mallon | Chief Executive Officer | 26 فبراير، 2021 S | 470605 | 0 | 0 | $0 |
| Peter M. Hecht | Chief Executive Officer | 1 إبريل، 2019 D | 2217366 | 0 | 0 | $0 |
| Gregory S. Martini | Chief Financial Officer | 10 مارس، 2026 A | 297213 | 0 | 2 | $-81888 |
| Sravan Kumar Emany | SVP, COO and CFO | 18 نوفمبر، 2024 S | 309572 | 0 | 0 | $0 |
| Gina Consylman | SVP, CFO & Treasurer | 26 مارس، 2021 A | 392616 | 0 | 0 | $0 |
| Jason Rickard | SVP, Chief Operating Officer | 8 مارس، 2023 A | 376316 | 0 | 0 | $0 |
| William Huyett | Chief Operating Officer | 1 إبريل، 2019 D | 27546 | 0 | 0 | $0 |
| Michael J Higgins | Chief Operating Officer | 23 ديسمبر، 2014 M | 329102 | 0 | 0 | $0 |
| Jeffrey Silber | SVP, CMO, Head-Res&Drug | 20 يوليو، 2026 A | 137036 | 0 | 0 | $0 |
| Ronald Silver | PFO & PAO | 7 يوليو، 2026 S | 313680 | 0 | 4 | $-831183 |
| Tammi L Gaskins | Chief Commercial Officer | 10 مارس، 2026 A | 350350 | 0 | 3 | $-100301 |
| Minardo John | Chief Legal Officer | 10 مارس، 2026 A | 500498 | 0 | 2 | $-136177 |
| Michael Shetzline | SVP, CMO, Head-Res&Drug | 10 مارس، 2026 A | 658037 | 0 | 2 | $-121586 |
| Andrew Davis | SVP, Chief Business Officer | 18 نوفمبر، 2024 S | 284685 | 0 | 0 | $0 |
| Conor Kilroy | SVP, GC & Secretary | 26 فبراير، 2021 S | 122336 | 0 | 0 | $0 |
| Kelly Macdonald | Chief Accounting Officer | 4 ديسمبر، 2020 M | 93041 | 0 | 0 | $0 |
| Halley E Gilbert | Chief Admin Officer & SVP | 21 فبراير، 2020 S | 265991 | 0 | 0 | $0 |
| Catherine Moukheibir | مدير | 16 يونيو، 2026 A | 181425 | 0 | 0 | $0 |
| Jon R Duane | مدير | 16 يونيو، 2026 A | 253820 | 0 | 0 | $0 |
| Marla L Kessler | مدير | 16 يونيو، 2026 A | 229364 | 0 | 0 | $0 |
| Jay Shepard | مدير | 16 يونيو، 2026 A | 235036 | 0 | 0 | $0 |
| Julie Mchugh | مدير | 16 يونيو، 2026 S | 250749 | 0 | 1 | $-80460 |
| Mark G Currie | مدير | 16 يونيو، 2026 A | 676900 | 0 | 0 | $0 |
| DENNER ALEXANDER J | مدير | 16 يونيو، 2026 A | 323855 | 0 | 2 | $-20530448 |
| Andrew Dreyfus | مدير | 10 يونيو، 2025 A | 228313 | 0 | 0 | $0 |
| Edward P Owens | مدير | 2 يونيو، 2021 A | 241720 | 0 | 0 | $0 |
| Lawrence S Olanoff | مدير | 2 يونيو، 2021 A | 91395 | 0 | 0 | $0 |
| Amy Schulman | مدير | 1 إبريل، 2019 D | 38242 | 0 | 0 | $0 |
| Marsha Fanucci | مدير | 1 إبريل، 2019 D | 132663 | 0 | 0 | $0 |
| Douglas E Williams | مدير | 1 إبريل، 2019 D | 87800 | 0 | 0 | $0 |
| Terrance McGuire | مدير | 1 إبريل، 2019 D | 73630 | 0 | 0 | $0 |
| WALSH CHRISTOPHER T PHD | مدير | 15 مارس، 2017 A | 71499 | 0 | 0 | $0 |
| George N Conrades | مدير | 3 يونيو، 2015 A | 62221 | 0 | 0 | $0 |
| David A Ebersman | مدير | 13 مارس، 2015 A | 29714 | 0 | 0 | $0 |
| COOK JOSEPH C JR | مدير | 12 مارس، 2015 S | 304080 | 0 | 0 | $0 |
| David Evans Shaw | مدير | 14 مارس، 2014 A | 64306 | 0 | 0 | $0 |
| FMR LLC | مالك 10% | 10 يوليو، 2012 S | 2340891 | 0 | 0 | $0 |
| Thomas Graney | — | 27 فبراير، 2017 A | 42013 | 0 | 0 | $0 |
| Bryan E Roberts | — | 15 يونيو، 2015 A | 31951 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
الناشطون والمالكون بنسبة 5%+ 4 حيازات
المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.
| مقدم | مقدم | حصة | الحالة | الغرض | إيداع |
|---|---|---|---|---|---|
| Sarissa Capital Management LP, Alexander J. Denner | 19 مارس، 2026 | 5,80% | تعديل | — | SEC |
| Ironwood Pharmaceuticals, Inc. | 7 يوليو، 2023 | — | إيداع أولي | اندماج واستحواذ / بيع | SEC |
| OR ×3 إيداعات | 1 مارس، 2021 | — | إيداع أولي | — | SEC |
| 9 نوفمبر، 2020 | — | إيداع أولي | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 41 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,85% | 77097 NS | 30 إبريل، 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,60% | 31360 SH | 19 أغسطس، 2026 | يومي |
| LABU · Direxion Shares ETF Trust | 0,19% | 233156 NS | 30 إبريل، 2026 | N-PORT |
| IWC · iShares Trust | 0,16% | 561624 SH | 19 أغسطس، 2026 | يومي |
| CALF · Pacer Funds Trust | 0,13% | 1123536 NS | 30 إبريل، 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,13% | 267285 SH | 19 أغسطس، 2026 | يومي |
| VFMO · VANGUARD WELLINGTON FUND | 0,11% | 521040 SH | 19 أغسطس، 2026 | يومي |
| FNDA · SCHWAB STRATEGIC TRUST | 0,10% | 2465723 NS | 31 مايو، 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,08% | 450064 NS | 30 إبريل، 2026 | N-PORT |
| IBB · iShares Trust | 0,05% | 1166745 SH | 19 أغسطس، 2026 | يومي |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,05% | 9112 SH | 19 أغسطس، 2026 | يومي |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 273163 SH | 19 أغسطس، 2026 | يومي |
| IWO · iShares Trust | 0,04% | 1385007 SH | 19 أغسطس، 2026 | يومي |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,04% | 165563 SH | 19 أغسطس، 2026 | يومي |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,03% | 43650 NS | 30 إبريل، 2026 | N-PORT |
| BIB · ProShares Trust | 0,03% | 6028 NS | 31 مايو، 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,03% | 73969 NS | 31 مايو، 2026 | N-PORT |
| IWM · iShares Trust | 0,02% | 4213885 SH | 19 أغسطس، 2026 | يومي |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 943404 SH | 19 أغسطس، 2026 | يومي |
| RSSL · Global X Funds | 0,02% | 69316 NS | 30 إبريل، 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,02% | 522300 NS | 30 إبريل، 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 7530 NS | 31 مايو، 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 689826 NS | 31 مايو، 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1677357 SH | 19 أغسطس، 2026 | يومي |
| VHT · VANGUARD WORLD FUND | 0,01% | 437643 SH | 19 أغسطس، 2026 | يومي |
| UWM · ProShares Trust | 0,01% | 5889 NS | 31 مايو، 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0,01% | 26377 NS | 31 مايو، 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 5956 NS | 31 مايو، 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 7151 NS | 31 مايو، 2026 | N-PORT |
| IWN · iShares Trust | 0,00% | 92332 SH | 19 أغسطس، 2026 | يومي |
| HDG · ProShares Trust | 0,00% | 150 NS | 31 مايو، 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 11833 NS | 30 إبريل، 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 197961 SH | 19 أغسطس، 2026 | يومي |
| IWV · iShares Trust | 0,00% | 41159 SH | 19 أغسطس، 2026 | يومي |
| DFAC · Dimensional ETF Trust | 0,00% | 100870 NS | 30 إبريل، 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 86390 NS | 31 مايو، 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 10643 NS | 30 إبريل، 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 4781484 SH | 19 أغسطس، 2026 | يومي |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9494 SH | 19 أغسطس، 2026 | يومي |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 13354 SH | 19 أغسطس، 2026 | يومي |
| SMLF · iShares Trust | — | 371456 SH | 19 أغسطس، 2026 | يومي |